Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
0.9000
Sep 30 • 3:59 PM ET Dollar change+0.2090 Percentage change(30.25%)
Aftermarket Close
0.8917
Aftermarket • 4:46 PM ET Dollar change-0.0083 Percentage change(-0.92%)
Today, 3:02 PMNo clear catalyst identified for AHG 25% regular-session advance after midday spike
Index
-
Market Cap
768.64M
Enterprise Value
770.84M
Income
-18.74M
Sales
13.88M
Book/sh
0.21
Cash/sh
0.00
Employees
12
IPO
Nov 03, 2017
P/E
-
Forward P/E
-
PEG
-
P/S
55.38
P/B
4.26
P/C
4521.39
P/FCF
-
EV/EBITDA
-
EV/Sales
55.54
Quick Ratio
21.74
Current Ratio
21.77
Debt/Eq
0.01
LT Debt/Eq
0.00
Option/Short
No / Yes
EPS (ttm)
-0.02
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS past 3/5Y
24.09% 59.38%
Sales past 3/5Y
1.86% 51.13%
EPS Y/Y TTM
95.22%
Sales Y/Y TTM
-6.20%
EPS Q/Q
40.26%
Sales Q/Q
25.62%
Earnings
-
EPS/Sales Surpr.
- -
Insider Own
-
Insider Trans
-
Inst Own
0.03%
Inst Trans
22.97%
ROA
-8.35%
ROE
-9.86%
ROIC
-10.36%
Gross Margin
-8.39%
Oper. Margin
-28.93%
Profit Margin
-135.08%
SMA20
14.88%
SMA50
-15.35%
SMA200
-41.07%
Trades
Shs Outstand
854.04M
Shs Float
22.85M
52W High
2.50 -64.00%
52W Low
0.68 32.14%
Volatility
11.77% 10.65%
ATR (14)
0.11
RSI (14)
53.19
Beta
-0.98
Rel Volume
388.12
Avg Volume
14.37K
Volume
5,579,205
Perf Week
16.90%
Perf Month
0.00%
Perf Quarter
-40.40%
Perf Half Y
-60.53%
Perf YTD
-45.12%
Perf Year
-47.98%
Perf 3Y
-13.14%
Perf 5Y
-59.82%
Perf 10Y
-
Prev Close
0.69
Price
0.90
Change %
30.25%
Apr-27-26 09:00AM
Mar-16-26 08:36PM
Feb-03-26 09:00AM
Feb-18-25 08:30AM
Jul-02-24 07:40AM
06:45AM Loading…
May-30-24 06:45AM
Jan-31-24 04:00PM
Oct-16-23 10:30AM
Apr-27-23 10:30AM
Mar-06-23 04:05PM
Oct-28-22 04:10PM
Aug-17-22 06:00AM
Jan-19-22 05:38PM
Akso Health Group operates a social e-commerce platform principally in China that collaborates with other domestic e-commerce platforms and offers users a wide selection of products. It also plans to develop a new business as a cancer therapy and radiotherapy oncology service provider with operations in the U.S. The firm plans to open 2 vaccine research centers and 100 radiation oncology centers to be located on the east coast serving cancer patients in need of varying stages of treatment, including specialized radiation therapy centers for radiotherapy, personalized consultation, conventional treatment planning, and other cancer related treatment services. The company was founded by Xiaobo An in March 2014 and is headquartered in Qingdao, China.
CEO & Chairwoman of the BoardMs. Yilin Wang
Chief Financial OfficerMr. Zhongliang Xie